Filter
1307
Text search:
drug
regimens
Featured
167
327
Language
Document type
774
223
170
54
32
21
18
7
3
3
1
Countries / Regions
74
47
36
35
33
30
26
25
25
24
20
20
18
18
13
13
12
12
12
12
10
10
9
9
9
8
8
8
8
7
7
7
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
460
194
56
49
30
15
13
Toolboxes
299
223
62
49
40
30
30
24
22
18
16
11
11
9
6
4
4
4
2
2
2
2
1
1
CDC leads an international surveillance effort to estimate the occurrence of HIV drug resistance among people with HIV who are taking dolutegravir (DTG)-based treatments. This surveillance effort utilizes Cyclical Acquired HIV
...
ATIC Newsletter, Vol 15, Issue 1,
February 2022.
A survival guide for clinicans.
3rd edition.
HIV drug resistance strategies focus on prevention through adherence and treatment optimization, surveillance to monitor resistance trends, and innovation in new drugs and diagnostics. Key approaches include implementing national action plans, stren
...
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Moz
...
Preventing tuberculosis infection from progressing to tuberculosis disease is a crucial component of the goal to eliminate tuberculosis. When deciding on the use of tuberculosis preventive therapy among household contacts, policy makers regularly ask questions, such as whether tuberculosis preventiv
...
Southern African HIV Clinicians Society (SAHCS) Clinical Update, May 2022
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
Issue Brief 8th edition.
Framework for implementation.
The END TB Strategy.
